CIDRAP newsletters options
The Centers for Disease Control and Prevention (CDC) today announced the creation of Public Health AmeriCorps through a partnership with the federal agency for volunteering and national service, AmeriCorps. The new program will help recruit, develop, and train new public health leaders.
Study reveals a small link between school closures and worse mental health, particularly in older and minority students.
As global cases top 220 million, surges continue in Southeast Asia and Oceania.
About 100,000 Americans are currently hospitalized because of COVID-19.
Results from an observational cohort study of pregnant women indicated a 96% vaccine effectiveness (VE) against COVID-19 infection and an 89% VE against hospitalization for the Pfizer/BioNTech vaccine in pregnant women, according to a study in Nature Medicine today.
A new study by researchers in Pakistan details the impact and response to treatment among children diagnosed as having extensively drug-resistant (XDR) typhoid infections.
The US surge has driven child COVID-19 hospitalization rates to pandemic highs.
The state has stepped into oxygen negotiations, created resource depots, and taken other actions.
Also, Africa is struggling to meet its end-of-September vaccination coverage goal of 10%.
None of the specified outcomes in 6.2 million vaccine recipients met the criteria for a safety signal.
COVID-19 vaccine effectiveness (VE) against the Delta (B1617.2) variant was 65% in those fully vaccinated, according to a population-based study in Norway. The results, published in Eurosurveillance yesterday, looked at 4,204,859 infected adults without previous COVID-19 from mid-April to mid-August.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A survey across 73 countries assessing the impact of COVID-19 on the prevention and control of antimicrobial resistance (AMR) highlights reduced availability of nursing, medical, and public health staff for AMR efforts. The study was published today in the Journal of Antimicrobial Chemotherapy.
The ECDC says a third dose should already be considered in the immune-compromised.
After years of decline, US hospitals saw significant increases in HAIs.
The odds of long COVID-19 fall by more than half after two doses of vaccine.
"A transparent, thorough, and objective review of the data by the FDA is critical."
The rheumatoid arthritis drug baricitinib was shown to reduce mortality in hospitalized COVID-19 patients, according to a randomized, controlled trial published in The Lancet Respiratory Medicine yesterday. Baricitinib acts as a Janus kinases inhibitor and is under emergency use authorization to treat severe COVID-19 by the US Food and Drug Administration.
Also, global health experts call on world leaders to hold a UN summit on ending the pandemic.
Even those who had mild COVID-19 are at increased risk for major declines in kidney function.
